Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00351039 | Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 8 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT01026844 | Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 27 | Massachusetts General HospitalOTHER | 1 | Jan 30, 2017 |
| clinicaltrials |
| NCT00921310 | Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 12 | Washington University School of MedicineOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00565227 | Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. | terminated | Phase 1 | 12 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 2, 2016 | clinicaltrials |
| NCT01886573 | Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery | terminated | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02083679 | Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer | terminated | Phase 1 | 15 | EMD SeronoINDUSTRY | 2 | Oct 25, 2016 | clinicaltrials |
| NCT01829971 | A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | terminated | Phase 1 | 155 | Mirna Therapeutics, Inc.INDUSTRY | 2 | Sep 27, 2016 | clinicaltrials |
| NCT00702572 | Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 | 25 | Milton S. Hershey Medical CenterOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT01915524 | Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 26 | CureVacINDUSTRY | 3 | Aug 5, 2016 | clinicaltrials |
| NCT01528137 | Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer | terminated | Phase 1 | 4 | Stanford UniversityOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT00417248 | Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 8 | Nasser Hanna, M.D.OTHER | 1 | Jul 25, 2016 | clinicaltrials |
| NCT00692380 | Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC | terminated | Phase 1 | 28 | Virginia Commonwealth UniversityOTHER | 1 | May 2, 2016 | clinicaltrials |
| NCT01565772 | Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer | terminated | Phase 1 | 4 | Massachusetts General HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01411098 | Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | terminated | Phase 1 | 6 | University of WashingtonOTHER | 1 | Nov 4, 2015 | clinicaltrials |
| NCT02134886 | Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection | terminated | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01193881 | RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00907179 | Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 | 12 | University of PittsburghOTHER | 1 | Jul 22, 2015 | clinicaltrials |
| NCT00378404 | Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC | terminated | Phase 1 | 10 | Susanne ArnoldOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01222572 | Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 1 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT00707252 | Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer | terminated | Phase 1 | 11 | Louisiana State University Health Sciences Center ShreveportOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01714037 | A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC](HALO) | terminated | Phase 1 | 82 | Debiopharm International SAINDUSTRY | 3 | Apr 8, 2015 | clinicaltrials |
| NCT00251589 | A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025) | terminated | Phase 1 / Phase 2 | 23 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 6, 2015 | clinicaltrials |
| NCT00511576 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | terminated | Phase 1 | 54 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT00975767 | A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer | terminated | Phase 1 | 126 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT02127372 | Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 | terminated | Phase 1 / Phase 2 | 43 | Duke UniversityOTHER | 0 | Sep 15, 2014 | clinicaltrials |
| NCT02209727 | Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | terminated | Phase 1 | 9 | Boehringer IngelheimINDUSTRY | 0 | Aug 6, 2014 | clinicaltrials |
| NCT00787852 | A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 11 | Brown UniversityOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT00614484 | Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer | terminated | Phase 1 / Phase 2 | 28 | Loma Linda UniversityOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00088933 | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT01641575 | A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin | terminated | Phase 1 | 8 | Clovis Oncology, Inc.INDUSTRY | 2 | Mar 11, 2014 | clinicaltrials |
| NCT00369551 | Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Mar 6, 2014 | clinicaltrials |
| NCT01063478 | Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC(RAD001) | terminated | Phase 1 | 3 | University of ChicagoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00265603 | Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer | terminated | Phase 1 | 16 | Atlantic Health SystemOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01060514 | Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer | terminated | Phase 1 | 8 | Northwestern UniversityOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01282333 | Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00937482 | Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer | terminated | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00042835 | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | terminated | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT01124812 | 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 3 | Philogen S.p.A.INDUSTRY | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00093132 | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | terminated | Phase 1 / Phase 2 | 20 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT01373463 | Cisplatin and Pemetrexed With Radiation Followed by Lobectomy(CisPemXetSrg) | terminated | Phase 1 | 48 | Medical University of South CarolinaOTHER | 1 | Jul 26, 2012 | clinicaltrials |
| NCT00522938 | Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 2 | Chroma TherapeuticsINDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00369447 | A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 52 | YM BioSciencesINDUSTRY | 3 | Jul 1, 2011 | clinicaltrials |
| NCT00539331 | Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients | terminated | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 1, 2011 | clinicaltrials |
| NCT00354562 | A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 75 | AbbottINDUSTRY | 4 | Jan 7, 2011 | clinicaltrials |
| NCT00491699 | Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer | terminated | Phase 1 | 2 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 19, 2010 | clinicaltrials |
| NCT00473486 | Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib(PECASO) | terminated | Phase 1 / Phase 2 | 12 | University Hospital MuensterOTHER | 1 | Jan 27, 2010 | clinicaltrials |
| NCT00264134 | Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 40 | Kentuckiana Cancer InstituteOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00461110 | A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) | terminated | Phase 1 | 35 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 4, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Mar 23, 2017source: clinicaltrials